secukinumab
novartis
['psoriatic arthritis', 'secukinumab']
happening today! #prcsg at #acr22! join us! efficacy of secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis subtypes of juvenile idiopathic arthritis: results from a randomized, phase 3 study abstract id: 2209 oral presentation: november 14, 3:00-3:10pm
The mission of the PRCSG is to conduct high quality clinical trials, of therapeutic agents, in children with rheumatic diseases.